GeneDx Holdings Corp. (WGS) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $33.28M | +216.8% |
| 2024 | -$28.50M | +84.2% |
| 2023 | -$180.15M | +43.6% |
| 2022 | -$319.15M | -67.6% |
| 2021 | -$190.43M | -104.5% |
| 2020 | -$93.13M | -397.3% |
| 2019 | -$18.73M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $33.28M | +216.8% |
| 2024 | -$28.50M | +84.2% |
| 2023 | -$180.15M | +43.6% |
| 2022 | -$319.15M | -67.6% |
| 2021 | -$190.43M | -104.5% |
| 2020 | -$93.13M | -397.3% |
| 2019 | -$18.73M | — |